Related Experiment Videos
Correlation between p53 mutation and cyclin D1 amplification in had and neck squamous cell carcinoma
Oral Oncology
|January 1, 1997
Summary
Mutations in the p53 tumor suppressor gene and cyclin D1 (CCND1) oncogene were investigated in head and neck cancers. A significant correlation was found, suggesting p53 mutation may precede CCND1 amplification in cancer development.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- p53 tumor suppressor gene mutations and cyclin D1 (CCND1) oncogene amplification are frequent in malignancies.
- Understanding the interplay between these genetic alterations is crucial for cancer research.
Purpose of the Study:
- To investigate the co-occurrence and correlation of p53 mutations and CCND1 amplification in squamous cell carcinomas of the head and neck.
- To explore the potential sequence of these genetic events in head and neck carcinogenesis.
Main Methods:
- Analysis of p53 mutations in coding sequences (exons 5, 6, 7, 8) using sequencing.
- Detection of CCND1 gene amplification using relevant molecular techniques.
- Statistical analysis to determine the correlation between p53 mutations and CCND1 amplification in 39 head and neck squamous cell carcinoma samples.
Main Results:
- p53 mutations were identified in 11 (28%) of cases, with mutations located in exons 5, 6, and 8.
- CCND1 amplification was observed in 6 (16%) of analyzed tumors.
- All tumors with CCND1 amplification also exhibited p53 mutations; 5 additional tumors had p53 mutations without CCND1 amplification, showing a significant positive correlation.
Conclusions:
- A statistically significant positive correlation exists between p53 mutations and CCND1 amplification in head and neck squamous cell carcinomas.
- The findings suggest that p53 mutation may be an early event that precedes CCND1 amplification during head and neck cancer development.